U.S. Mortgage Finance Stock News

NYSE:FBP
NYSE:FBPBanks

How Epstein-Linked Lawsuit Over Acquired Accounts At First BanCorp (FBP) Has Changed Its Investment Story

In late June 2026, First BanCorp, the holding company for FirstBank Puerto Rico, confirmed it had been sued in the U.S. District Court for the Southern District of New York over banking services provided to Jeffrey Epstein following a U.S. Virgin Islands bank acquisition, and stated it would vigorously contest the allegations. The case introduces fresh legal and reputational questions for First BanCorp, directly intersecting with its public emphasis on strong BSA/AML controls and ethical...
NYSE:ATEN
NYSE:ATENSoftware

A10 Networks (ATEN) Leaves Russell Indexes As Valuation Questions Build

What A10 Networks’ Index Removal Means for Investors A10 Networks (ATEN) has been removed from several Russell benchmarks, including the Russell 2000 Value, Russell Microcap, and Russell 3000E indices. This type of change can trigger meaningful trading as index-tracking funds rebalance. Broad index removal can lead to mechanical selling by passive funds that track these benchmarks. This activity can influence trading volumes and short term price behavior without necessarily reflecting any...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Is GLOBALFOUNDRIES (GFS) A Bargain As Its SEALSQ Partnership Fuels Valuation Debate?

GLOBALFOUNDRIES (GFS) drew fresh attention after SEALSQ Corp announced a memorandum of understanding to work together on secure semiconductor platforms, Post Quantum Cryptography, and semiconductor based quantum computing technologies. See our latest analysis for GLOBALFOUNDRIES. The new SEALSQ agreement comes as GLOBALFOUNDRIES trades at US$67.97, with a 1 day share price return of 3.24% after a 7 day share price decline of 11.99%. The 90 day share price return of 39.57% and year to date...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

Merit Medical Systems (MMSI) Could Be 21% Below Fair Value Following Splashwire Recall

Why Merit Medical Systems stock is in focus after the Splashwire recall Merit Medical Systems (MMSI) is drawing attention after a voluntary Class II recall of over 5,000 Splashwire Hydrophilic Guide Wire units. The development is raising questions about quality controls, customer relationships, and any knock on effects for product availability. See our latest analysis for Merit Medical Systems. Merit Medical Systems' share price has recently been under pressure, with the year to date share...
NYSE:WMB
NYSE:WMBOil and Gas

Williams Companies (WMB) Is Back In Focus As Index Changes Test Its Valuation

Why Williams Companies stock is back in focus Williams Companies (WMB) has moved back onto investors’ radar after being dropped from several Russell growth indices, a shift that can influence trading flows as index funds adjust their positions. The changes affect benchmarks such as the Russell 1000 Growth, Russell 3000 Growth, Russell Top 200 Growth and related sub indices, where passive vehicles often track constituent lists closely when rebalancing portfolios. See our latest analysis for...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital (WDC) Stock Still Trades Below Fair Value Despite Huge Run

Western Digital has been one of the strongest performers in the memory and AI hardware space over the past few years. However, its current share price still sits well below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach, creating a clear tension between rapid share price gains and what the valuation work suggests. Over the past 3 years, Western Digital has delivered a return of roughly 18x, which puts recent volatility and short term pullbacks into the context of...
NYSE:COF
NYSE:COFConsumer Finance

Capital One Stock And 2 Banks for Higher Interest Rates

Chile’s latest inflation surprise, with flat consumer prices in June and interest rates held at 4.5%, is a reminder that financial markets can react quickly when price pressures linger and central banks stay cautious. For investors in financial services stocks, those stubborn inflation readings and the IMF’s warning on global risks, including copper price swings, can change how banks, insurers, and asset managers are priced and perceived. This article walks through 3 stocks from our Financial...
NasdaqGS:SRAD
NasdaqGS:SRADHospitality

Could Sportradar Group (SRAD) Be 24% Undervalued As Class Actions Raise Fresh Doubts?

Class action lawsuits accusing Sportradar Group (NasdaqGS:SRAD) of collaborating with black market gambling operators and misrepresenting compliance practices have quickly become a central factor for anyone assessing the stock today. See our latest analysis for Sportradar Group. Sportradar Group’s recent class action headlines sit against a mixed performance picture, with a 1 day share price return of 1.89% to US$16.16 and a 7 day share price return of 6.88%, but a year to date share price...
NYSE:DHI
NYSE:DHIConsumer Durables

HCA Healthcare Stock And 2 More Names Facing The Next US Immigration Test

Immigration is back in the headlines, and that matters for your portfolio. With birthright citizenship affirmed but new court challenges floated, some stocks exposed to US immigration policy may see clearer hiring and demand trends, while others could face renewed political risk and valuation pressure. This article breaks down 3 stocks tied to labor reliant industries, all filtered through our Immigration Policy Impact Stocks Across Labor Reliant Industries screener. Two appear positioned to...
NYSE:MDT
NYSE:MDTMedical Equipment

Medtronic (MDT) Following Octopus 4 Recall Has An Undervalued Narrative Under Review

What Medtronic’s Octopus 4 Recall Means for Investors Medtronic (MDT) has initiated a voluntary Class II recall of its Octopus 4 Tissue Stabilizer after identifying incorrectly positioned tubing in 590 units, raising fresh questions about quality controls and potential financial exposure. The recall, disclosed in a US Food and Drug Administration enforcement report, was started by Medtronic Perfusion Systems on May 12, 2026, and is described as ongoing, with worldwide and US nationwide...
NasdaqGM:TTD
NasdaqGM:TTDMedia

Trade Desk (TTD) Clears Publicis Dispute As Fox Roku Talk Opens New Questions

Trade Desk resolved its dispute with major advertising agency Publicis, removing a key operational hurdle in its agency relationships. Commentary around the proposed Fox Roku merger highlights potential new connected TV opportunities for Trade Desk. These developments arrive after a period of concern about Trade Desk's market share and competitive position in adtech. Trade Desk, listed as NasdaqGM:TTD, is back in focus after clearing an important overhang with Publicis and being linked to...
NYSE:LEN
NYSE:LENConsumer Durables

PulteGroup Stock Faces The Biggest Test From Fed Rate Uncertainty

The latest Federal Reserve minutes put interest rate policy firmly in the spotlight, with officials split on whether cuts or hikes are coming next and inflation still pressured by tariffs and the Iran war. That uncertainty around rates, inflation trends and Treasury yields can quickly reshape the risk and reward profile for individual stocks. This article walks through three stocks that are particularly exposed to this news, with one that could benefit from higher policy volatility and two...
NYSE:DT
NYSE:DTSoftware

How Investors May Respond To Dynatrace (DT) Pursuing FedRAMP High For U.S. Government Workloads

In early July 2026, Dynatrace announced it is pursuing FedRAMP High authorization, building on its existing FedRAMP Moderate status and expanding capabilities for highly regulated U.S. government and public sector workloads. This move signals a deeper push into compliance-heavy environments where its unified observability platform and Grail data lakehouse are being positioned for stricter federal security requirements. We’ll now examine how Dynatrace’s FedRAMP High push could influence its...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

Power Integrations (POWI) Stock Still Looks Expensive On Fresh Analyst Target Hikes

Power Integrations stock has surged 78.2% year to date, yet based on current checks it still screens as expensive rather than a clear bargain. That creates a tension for investors between strong recent momentum and valuation metrics that point to a premium. The 78.2% gain year to date indicates that expectations for Power Integrations have reset sharply higher and may leave less room for disappointment. Recent analyst interest in Power Integrations' high power GaN portfolio and product...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Protagonist Therapeutics (PTGX) Could Be 66% Below Fair Value As Pipeline Progress Lifts Interest

Protagonist Therapeutics (PTGX) drew fresh attention after its stock climbed 7.1% on heavier than usual trading, as investors focused on key pipeline milestones and recent FDA activity related to rusfertide and Icotyde. See our latest analysis for Protagonist Therapeutics. At a share price of $140.07, Protagonist Therapeutics has seen strong momentum recently, with a 30 day share price return of 42.88% and a 1 year total shareholder return of 167.87%, which may indicate that investors are...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

NANO Nuclear Energy (NNE) Faces A Valuation Test On Russell Index Removal

NANO Nuclear Energy (NNE) was removed from several Russell growth benchmarks, including the Russell 3000 and Russell 2000. This coordinated index change can influence trading as index-tracking funds adjust their holdings. See our latest analysis for NANO Nuclear Energy. The index removals come at a time when NANO Nuclear Energy’s share price has been under pressure, with a 30-day share price return of down 26.65% and a year-to-date share price return of down 31.33%. The 1-year total...
NYSE:GNRC
NYSE:GNRCElectrical

Tenable Stock Leads 3 Cash Rich Tech Names Trading Below Estimated Fair Value

With inflation, interest rates and geopolitics all pulling markets in different directions, reliable cash generation has become a key focus for many investors. The Undervalued Stocks Based On Cash Flows screener targets companies where current prices sit below an internally assessed fair value using SWS DCF valuation, even as those businesses show promising cash flow potential. That combination can be appealing if you are looking for value-oriented ideas that are grounded in fundamentals...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Does ACMR’s Shift Into Russell Growth Indices Reframe Its China‑Focused Expansion Story?

In late June 2026, ACM Research, Inc. was removed from several Russell value benchmarks and simultaneously added to multiple Russell growth and growth‑defensive indices, including the Russell 3000 Growth, 3000E Growth, 2500 Growth, and 2000 Growth benchmarks. This reclassification from value to growth indices highlights how index providers now view ACM Research as more closely aligned with growth-oriented semiconductor equipment peers, which may influence which institutional investors hold...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Fiserv (FISV) Stock May Be Undervalued As STAR Sale Talks Swirl

Fiserv stock has fallen 70.4% over the past year, yet on current checks it still screens as undervalued, leaving investors weighing whether the recent selloff has pushed the price below what the fundamentals may justify. Fiserv shares are down 70.4% over the last 12 months, which suggests sentiment has reset sharply and the market is pricing in considerable execution and risk concerns. Talks to potentially sell the STAR debit network and ongoing leadership changes can support a more focused...
NYSE:IQV
NYSE:IQVLife Sciences

IQVIA Holdings (IQV) Draws Undervalued Attention, Is The Recent Momentum Fully Priced In?

IQVIA Holdings (IQV) has drawn investor attention after recent share price moves, with the stock last closing at US$203.79. The company now carries an equity value of about US$34.75b in the healthcare data and research space. See our latest analysis for IQVIA Holdings. Recent trading has been choppy for IQVIA Holdings, with the share price falling 2.13% over the last day but gaining 10.94% over 1 month and 20.60% over 3 months. The 1 year total shareholder return of 25.78% contrasts with...
NYSE:SKT
NYSE:SKTRetail REITs

Is Tanger (SKT) Stock Above Fair Value After A 151% Run?

Tanger stock has delivered a strong 151.2% return over the past five years. At a recent price of US$39.16, the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples both suggest it no longer looks obviously cheap or clearly stretched. A 151.2% five year return means early shareholders have already seen substantial gains, so fresh buyers now need to pay closer attention to what they are getting for the current price. For a real estate focused company like Tanger, investor...
NYSE:CBZ
NYSE:CBZProfessional Services

Is CBIZ’s (CBZ) Shift Into Russell Value Indexes Recasting Its Core Investment Identity?

In late June 2026, CBIZ, Inc. (NYSE:CBZ) was rebalanced across several Russell indexes, being added to multiple value-focused benchmarks and removed from various growth-oriented indices. This broad shift toward value classifications may influence how quantitative and index-based investors view CBIZ’s profile within the professional services space. We’ll now examine how CBIZ’s increased inclusion in value-oriented Russell benchmarks interacts with its existing investment narrative and...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

NextDecade (NEXT) Is Up 7.4% After Broad Russell Value Index Additions Signal New Investor Attention

In late June 2026, NextDecade Corporation was added to several Russell value and small‑cap benchmarks, including the Russell 2000 Value and Russell 3000 Value indices, marking a significant index inclusion milestone for the LNG developer. This broad Russell index inclusion can be important because it often brings the company onto the radar of index‑tracking funds and institutional investors that allocate capital based on these benchmarks. Now we’ll examine how inclusion in multiple Russell...
NYSE:MPC
NYSE:MPCOil and Gas

Marathon Petroleum (MPC) Stock Looks Cheap Even With Mixed Valuation Signals

Marathon Petroleum has delivered a very large 5 year gain for shareholders, yet its current share price around US$280.68 still screens below an intrinsic value estimate from a Discounted Cash Flow (DCF) model, while the broader valuation checks point to a more mixed picture. Over the past 5 years, Marathon Petroleum has returned roughly 4.7x an initial investment. This puts extra focus on whether the current valuation leaves enough room for future upside. A softer crude price backdrop can...